Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

LONA

LeonaBio, Inc.

Tremor tracks 1 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

  • LONALeonaBio
    0Calm

    Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

    Signing up patientsPhase 3600 patientsMain results: Apr 2027

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

0 sales (0 not pre-planned) · 1 purchase

  • Portman David J.Large shareholder · Oct 26, 2026Bought 3,149,470 sharesabout $9919.2 million ·

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • Other newsNews report (8-K)Sep 22, 2026
  • Other newsNews report (8-K)Aug 26, 2026
  • Quarterly reportQuarterly report (10-Q)Aug 14, 2026
  • Shared quarterly results; Shared information with investorsNews report (8-K)Aug 14, 2026
  • News reportNews report (8-K)Jun 23, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.